Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Injectable Flu Vaccine Has Not Discouraged Parents

Pediatrics; ePub 2017 Nov 1; Robison, et al

Recommending that children be switched from the live attenuated influenza vaccine, which is available as a nasal spray, to an injectable vaccine has not discouraged patients from getting the vaccine, according to a recent analysis of Oregon’s immunization registry. Highlights include:

  • The Advisory Committee on Immunization Practices stopped recommending the nasal spray before the 2016-2017 flu season began.
  • Despite the change in policy, vaccination rates among children ages 2 to 17 years remained unchanged between 2015-2016 and 2016-2017.
  • Children between the ages of 3 and 10 years who had a previous injectable vaccine were slightly more likely to have another injectable when they returned for their 2016-2017 vaccine, when compared to children with a previous nasal spray vaccine.
  • Children between the ages of 11 and 17 years were 1.08 times more likely to return for a second injectable vaccine.

Citation:

Robison SG, Dunn AG, Richards DL, Leman RF. Changes in influenza vaccination rates after withdrawal of live vaccine. [Published online ahead of print November 1, 2017]. Pediatrics. doi:10.1542/peds.2017-0516.